Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.

MLA

Jae Heon Kim, et al. “Efficacy and Safety of 5 Alpha-Reductase Inhibitor Monotherapy in Patients with Benign Prostatic Hyperplasia: A Meta-Analysis.” PLoS ONE, vol. 13, no. 10, Jan. 2018, p. e0203479. EBSCOhost, https://doi.org/10.1371/journal.pone.0203479.

APA

Jae Heon Kim, Min Jung Baek, Hwa Yeon Sun, Bora Lee, Shufeng Li, Yash Khandwala, Francesco Del Giudice, & Benjamin I Chung. (2018). Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis. PLoS ONE, 13(10), e0203479. https://doi.org/10.1371/journal.pone.0203479

Chicago

Jae Heon Kim, Min Jung Baek, Hwa Yeon Sun, Bora Lee, Shufeng Li, Yash Khandwala, Francesco Del Giudice, and Benjamin I Chung. 2018. “Efficacy and Safety of 5 Alpha-Reductase Inhibitor Monotherapy in Patients with Benign Prostatic Hyperplasia: A Meta-Analysis.” PLoS ONE 13 (10): e0203479. doi:10.1371/journal.pone.0203479.